Literature DB >> 17685090

Effects of astaxanthin supplementation on lipid peroxidation.

Jouni Karppi1, Tiina H Rissanen, Kristiina Nyyssönen, Jari Kaikkonen, Anders G Olsson, Sari Voutilainen, Jukka T Salonen.   

Abstract

Astaxanthin, the main carotenoid pigment in aquatic animals, has greater antioxidant activity in vitro (protecting against lipid peroxidation) and a more polar configuration than other carotenoids. We investigated the effect of three-month astaxanthin supplementation on lipid peroxidation in healthy non-smoking Finnish men, aged 19-33 years by using a randomized double-blind study design. Also absorption of astaxanthin from capsules into bloodstream and its safety were evaluated. The intervention group received two 4-mg astaxanthin (Astaxin) capsules daily, and the control group two identical-looking placebo capsules. Astaxanthin supplementation elevated plasma astaxanthin levels to 0.032 pmol/L (p < 0.001 for the change compared with the placebo group). We observed that levels of plasma 12- and 15-hydroxy fatty acids were reduced statistically significantly in the astaxanthin group (p = 0.048 and p = 0.047 respectively) during supplementation, but not in the placebo group and the change of 15-hydroxy fatty acid was almost significantly greater (p = 0.056) in the astaxanthin group, as compared with the placebo group. The present study suggests that intestinal absorption of astaxanthin delivered as capsules is adequate, and well tolerated. Supplementation with astaxanthin may decrease in vivo oxidation of fatty acids in healthy men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17685090     DOI: 10.1024/0300-9831.77.1.3

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  30 in total

1.  Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.

Authors:  Raffaele Serra; Raffaele Grande; Lucia Butrico; Gianluca Buffone; Francesco G Caliò; Aida Squillace; Barbara A Rizzo; Mafalda Massara; Francesco Spinelli; Alessia G Ferrarese; Giovanni de Caridi; Luca Gallelli; Stefano de Franciscis
Journal:  Int Wound J       Date:  2014-02-25       Impact factor: 3.315

2.  Asthaxanthin Improves Aerobic Exercise Recovery Without Affecting Heat Tolerance in Humans.

Authors:  Chen Fleischmann; Michal Horowitz; Ran Yanovich; Hany Raz; Yuval Heled
Journal:  Front Sports Act Living       Date:  2019-09-04

3.  Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects.

Authors:  Hye Duck Choi; Yeo Kyu Youn; Wan Gyoon Shin
Journal:  Plant Foods Hum Nutr       Date:  2011-11       Impact factor: 3.921

Review 4.  Functional foods and their role in cancer prevention and health promotion: a comprehensive review.

Authors:  Mohammad Aghajanpour; Mohamad Reza Nazer; Zia Obeidavi; Mohsen Akbari; Parya Ezati; Nasroallah Moradi Kor
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

Review 5.  Carotenoids and cardiovascular disease.

Authors:  Graziano Riccioni
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

6.  Stabilization of membrane bound ATPases and lipid peroxidation by carotenoids from Chlorococcum humicola in Benzo(a)pyrene induced toxicity.

Authors:  S Bhagavathy; P Sumathi
Journal:  Asian Pac J Trop Biomed       Date:  2012-05

7.  A Study on the Bioavailability of a Proprietary, Sustained-release Formulation of Astaxanthin.

Authors:  Doddabele Madhavi; Daniel Kagan; Supriya Seshadri
Journal:  Integr Med (Encinitas)       Date:  2018-06

Review 8.  Astaxanthin: a potential therapeutic agent in cardiovascular disease.

Authors:  Robert G Fassett; Jeff S Coombes
Journal:  Mar Drugs       Date:  2011-03-21       Impact factor: 5.118

Review 9.  Marine carotenoids and cardiovascular risk markers.

Authors:  Graziano Riccioni; Nicolantonio D'Orazio; Sara Franceschelli; Lorenza Speranza
Journal:  Mar Drugs       Date:  2011-06-27       Impact factor: 6.085

10.  Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial.

Authors:  Robert G Fassett; Helen Healy; Ritza Driver; Iain K Robertson; Dominic P Geraghty; James E Sharman; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2008-12-18       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.